Aristotle Atlantic Partners, LLC Adaptive Biotechnologies Corp Transaction History
Aristotle Atlantic Partners, LLC
- $3.26 Billion
- Q2 2025
A detailed history of Aristotle Atlantic Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 2,879,317 shares of ADPT stock, worth $36.5 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
2,879,317
Previous 2,941,212
2.1%
Holding current value
$36.5 Million
Previous $21.9 Million
53.5%
% of portfolio
1.03%
Previous 0.74%
Shares
24 transactions
Others Institutions Holding ADPT
# of Institutions
261Shares Held
149MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$380 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$143 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$79.2 Million1.68% of portfolio
-
Nikko Asset Management Americas, Inc.4.3MShares$54.4 Million0.53% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.81B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...